Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease: Comprehensive Approach and Adherence to Treatment: DIALCAT Project.

NCT03578991 is registered in ClinicalTrials.gov with Parc Sanitari Pere Virgili as lead sponsor.

NCT NCT03578991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03578991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease: Comprehensive Approach and Adherence to Treatment: DIALCAT Project.
Lead sponsor
Parc Sanitari Pere Virgili
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2019
Completion date
April 15, 2020
Enrollment
54 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diagnosed of mild cognitive impairment, diagnosed of type 2 diabetes in active treatment (hypoglycemic agents) for a period ≥5 years, patients aged 65-85 (both included)